BNY Mellon U.S. Equity Income GBP Sterling W Acc HRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | - | - | 8.2 | 16.0 | |
+/-Cat | - | - | - | 4.7 | 2.0 | |
+/-B’mrk | - | - | - | 8.6 | 0.9 | |
Category: US Equity Income | ||||||
Category Benchmark: Morningstar US High Div Yld... |
Key Stats | ||
NAV 21/11/2024 | GBP 1.30 | |
Day Change | 1.05% | |
Morningstar Category™ | US Equity Income | |
IA (formerly IMA) Sector | North America | |
ISIN | IE00BD7Y0G10 | |
Fund Size (Mil) 31/10/2024 | USD 675.69 | |
Share Class Size (Mil) 21/11/2024 | GBP 47.86 | |
Max Initial Charge | 5.00% | |
Ongoing Charge 25/10/2024 | 0.88% |
Investment Objective: BNY Mellon U.S. Equity Income GBP Sterling W Acc H |
The Sub-Fund aims to maximise total returns from income and capital growth. The Sub-Fund invests primarily (meaning at least two-thirds of the Sub-Fund's Net Asset Value) in equity and equity-related securities (common and preferred stock, American depositary receipts and global depository receipts (collectively “Depositary Receipts”), listed real estate investment trusts (“REITs”) and master limited partnerships (“MLPs”)), issued by “large-capitalisation companies” located in the U.S. The term “large-capitalisation companies” shall be taken to include securities of companies which, at the time of purchase, have a market capitalisation of US$2 billion or above. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
John Bailer 17/01/2017 | ||
Brian Ferguson 17/01/2017 | ||
Click here to see others | ||
Inception Date 16/11/2022 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
S&P 500 NR USD | Morningstar US High Div Yld NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for BNY Mellon U.S. Equity Income GBP Sterling W Acc H | 30/09/2024 |
|
|
Top 5 Holdings | Sector | % |
AT&T Inc | Communication Services | 4.64 |
Cisco Systems Inc | Technology | 4.24 |
Medtronic PLC | Healthcare | 3.99 |
L3Harris Technologies Inc | Industrials | 3.18 |
Sanofi SA ADR | Healthcare | 3.04 |
Increase Decrease New since last portfolio | ||
BNY Mellon U.S. Equity Income GBP Sterling W Acc H |